These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 1501232)
1. Improved brain delivery of AZT using a glycosyl phosphotriester prodrug. Namane A; Gouyette C; Fillion MP; Fillion G; Huynh-Dinh T J Med Chem; 1992 Aug; 35(16):3039-44. PubMed ID: 1501232 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and tissue distribution of (+/-)-3'-azido-2',3'-dideoxy-5'-O-(2-bromomyristoyl)thymidine, a prodrug of 3'-azido-2',3'-dideoxythymidine (AZT) in mice. Parang K; Wiebe LI; Knaus EE J Pharm Pharmacol; 1998 Sep; 50(9):989-96. PubMed ID: 9811159 [TBL] [Abstract][Full Text] [Related]
3. Brain targeting of anti-HIV nucleosides: synthesis and in vitro and in vivo studies of dihydropyridine derivatives of 3'-azido-2',3'-dideoxyuridine and 3'-azido-3'-deoxythymidine. Chu CK; Bhadti VS; Doshi KJ; Etse JT; Gallo JM; Boudinot FD; Schinazi RF J Med Chem; 1990 Aug; 33(8):2188-92. PubMed ID: 2374145 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of bis(t-butyl-SATE)-AZTMP, a bispivaloylthioethyl prodrug for intracellular delivery of zidovudine monophosphate, in mice. Tan X; Boudinot FD; Chu CK; Egron D; Perigaud C; Gosselin G; Imbach JL Antivir Chem Chemother; 2000 May; 11(3):203-11. PubMed ID: 10901291 [TBL] [Abstract][Full Text] [Related]
5. Novel approaches for designing 5'-O-ester prodrugs of 3'-azido-2', 3'-dideoxythymidine (AZT). Parang K; Wiebe LI; Knaus EE Curr Med Chem; 2000 Oct; 7(10):995-1039. PubMed ID: 10911016 [TBL] [Abstract][Full Text] [Related]
6. In vivo biodistribution, pharmacokinetic parameters, and brain uptake of 5-halo-y-methoxy(or ethoxy)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs of 3'-azido-3'-deoxythymidine. Wang L; Morin KW; Kumar R; Cheraghali M; Todd KG; Baker GB; Knaus EE; Wiebe LI J Med Chem; 1996 Feb; 39(4):826-33. PubMed ID: 8632406 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo pharmacokinetic characterization of two novel prodrugs of zidovudine. Quevedo MA; Briñón MC Antiviral Res; 2009 Aug; 83(2):103-11. PubMed ID: 19549583 [TBL] [Abstract][Full Text] [Related]
8. Adamantane as a brain-directed drug carrier for poorly absorbed drug. 2. AZT derivatives conjugated with the 1-adamantane moiety. Tsuzuki N; Hama T; Kawada M; Hasui A; Konishi R; Shiwa S; Ochi Y; Futaki S; Kitagawa K J Pharm Sci; 1994 Apr; 83(4):481-4. PubMed ID: 8046599 [TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetics of two prodrugs of zidovudine in rabbits: enhanced levels of zidovudine in brain tissue. Lupia RH; Ferencz N; Lertora JJ; Aggarwal SK; George WJ; Agrawal KC Antimicrob Agents Chemother; 1993 Apr; 37(4):818-24. PubMed ID: 8494380 [TBL] [Abstract][Full Text] [Related]
10. Brain, blood, and cerebrospinal fluid distribution of a zidovudine chemical delivery system in rabbits. Brewster ME; Anderson W; Bodor N J Pharm Sci; 1991 Sep; 80(9):843-6. PubMed ID: 1800706 [TBL] [Abstract][Full Text] [Related]
11. Ester prodrugs of zidovudine. Kawaguchi T; Ishikawa K; Seki T; Juni K J Pharm Sci; 1990 Jun; 79(6):531-3. PubMed ID: 2395099 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of amino acid phosphoramidate monoesters of zidovudine in rats. Song H; Griesgraber GW; Wagner CR; Zimmerman CL Antimicrob Agents Chemother; 2002 May; 46(5):1357-63. PubMed ID: 11959569 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of sulfonylethyl-containing phosphotriesters of 3'-azido-3'-deoxythymidine as anticancer prodrugs. Wang J; Wang YJ; Chen ZS; Kwon CH Bioorg Med Chem; 2014 Nov; 22(21):5747-56. PubMed ID: 25440502 [TBL] [Abstract][Full Text] [Related]
14. Disposition and oral bioavailability in rats of an antiviral and antitumor amino acid phosphoramidate prodrug of AZT-monophosphate. Song H; Johns R; Griesgraber GW; Wagner CR; Zimmerman CL Pharm Res; 2003 Mar; 20(3):448-51. PubMed ID: 12669967 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, in vitro and in vivo release kinetics, and anti-HIV activity of a sustained-release prodrug (mPEG-AZT) of 3'-azido-3'-deoxythymidine (AZT, Zidovudine). Li W; Chang Y; Zhan P; Zhang N; Liu X; Pannecouque C; De Clercq E ChemMedChem; 2010 Nov; 5(11):1893-8. PubMed ID: 20936623 [TBL] [Abstract][Full Text] [Related]
16. The effect of dihydronicotinate N-substitution on the brain-targeting efficacy of a zidovudine chemical delivery system. Brewster ME; Pop E; Braunstein AJ; Pop AC; Druzgala P; Dinculescu A; Anderson W; Elkoussi A; Bodor N Pharm Res; 1993 Sep; 10(9):1356-62. PubMed ID: 8234177 [TBL] [Abstract][Full Text] [Related]
17. Comparative pharmacokinetics of 3'-azido-3'-deoxythymidine (AZT) and 3'-azido-2',3'-dideoxyuridine (AZddU) in mice. Doshi KJ; Gallo JM; Boudinot FD; Schinazi RF; Chu CK Drug Metab Dispos; 1989; 17(6):590-4. PubMed ID: 2575492 [TBL] [Abstract][Full Text] [Related]
18. Brain uptake of a Zidovudine prodrug after nasal administration of solid lipid microparticles. Dalpiaz A; Ferraro L; Perrone D; Leo E; Iannuccelli V; Pavan B; Paganetto G; Beggiato S; Scalia S Mol Pharm; 2014 May; 11(5):1550-61. PubMed ID: 24717116 [TBL] [Abstract][Full Text] [Related]
19. Intracellular metabolism and pharmacokinetics of 5'-hydrogenphosphonate of 3'-azido-2',3'-dideoxythymidine, a prodrug of 3'-azido-2',3'-dideoxythymidine. Skoblov Y; Karpenko I; Shirokova E; Popov K; Andronova V; Galegov G; Kukhanova M Antiviral Res; 2004 Aug; 63(2):107-13. PubMed ID: 15302139 [TBL] [Abstract][Full Text] [Related]
20. Enhanced delivery of zidovudine through rat and human skin via ester prodrugs. Seki T; Kawaguchi T; Juni K Pharm Res; 1990 Sep; 7(9):948-52. PubMed ID: 2235895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]